Ellen N. Weinzapfel, PhD and Karlie Fedder-Semmes, PhD
Senior author Alberto Ciccia, PhD (left) and first author Giuseppe Leuzzi, PhD.
In this new blog series, we are sitting down with the lead scie…
Ellen N. Weinzapfel, PhD
2023 was a remarkable year for science. The first CRISPR-based gene therapy was approved in the U.K. and the U.S. for sickle-cell anemia,…
Karlie Fedder-Semmes, PhD
Precision medicine, also known as personalized or individualized medicine,
describes the use of patient-specific molecular features to guid…
Ellen N. Weinzapfel, PhD
CUT&Tag (Cleavage Under Targets & Tagmentation) is a breakthrough strategy
that combines immunotethering and Tn5-based tagmentation technol…
Karlie Fedder-Semmes, PhD and Ellen N. Weinzapfel, PhD
EpiCypher’s CUTANA™
CUT&RUN
and
CUT&Tag
technologies are enabling major advancements in high-resolution profiling of
histone post…
Ellen N. Weinzapfel, PhD
2022 was a big year for CUTANA™ CUT&RUN. EpiCypher now offers a complete
workflow with our CUTANA CUT&RUN
Assay Kit
and
Library Prep…